GlassScriptPhysician profile
Ashley Dishion
NPI 1770199598
$768.73
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $221 · 2022: $313 · 2023: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $127.93 | 2022-2023 | Glassia |
| Esperion Therapeutics, INC. | $119.20 | 2021 | |
| Abiomed | $112.17 | 2022 | |
| Medtronic, INC. | $101.45 | 2021 | |
| Gilead Sciences, INC. | $95.85 | 2022 | |
| Glaxosmithkline, LLC. | $57.32 | 2022-2023 | Arexvy, Trelegy Ellipta |
| Mylan Specialty L.P. | $50.53 | 2023 | Yupelri |
| Grifols USA, LLC | $38.40 | 2022-2023 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals LP | $32.50 | 2023 | Tezspire, Breztri |
| Novo Nordisk INC | $20.39 | 2023 | Wegovy |
| Teva Pharmaceuticals USA, INC. | $12.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Dishion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.